Literature DB >> 33907974

Differences in seroprevalence between epicenter and non-epicenter areas of the COVID-19 outbreak in South Korea.

Hye Won Jeong1,2, Hyun-Ha Chang3, Eun Ji Kim4, Yu Kyung Kim5, Se-Mi Kim4, Eun-Ha Kim4, Young-Il Kim4, Mark Anthony B Casel4, Seong-Gyu Kim4, Rare Rollon4, Seung-Gyu Jang4, Kwang-Min Yu4, Hee-Sung Kim2, Hee Sue Park6, Su-Jin Park7, Yong-Dae Kim8,9, Eung-Gook Kim4, Young Ki Choi10.   

Abstract

To compare the standardized severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence of high epicenter region with non-epicenter region, serological studies were performed with a total of 3,268 sera from Daegu City and 3,981 sera from Chungbuk Province. Indirect immunofluorescence assay (IFA) for SARS-CoV-2 IgG results showed a high seroprevalence rate in the Daegu City (epicenter) compared with a non-epicenter area (Chungbuk Province) (1.27% vs. 0.91%, P = 0.0358). It is noteworthy that the highest seroprevalence in Daegu City was found in elderly patients (70's) whereas young adult patients (20's) in Chungbuk Province showed the highest seroprevalence. Neutralizing antibody (NAb) titers were found in three samples from Daegu City (3/3, 268, 0.09%) while none of the samples from Chungbuk Province were NAb positive. These results demonstrated that even following the large outbreak, the seropositive rate of SARS-CoV-2 in the general population remained low in South Korea.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; South Korea; epicenter; seroprevalence

Year:  2021        PMID: 33907974      PMCID: PMC8079228          DOI: 10.1007/s12275-021-1095-7

Source DB:  PubMed          Journal:  J Microbiol        ISSN: 1225-8873            Impact factor:   3.422


  19 in total

1.  SARS-CoV-2 seroprevalence in COVID-19 hotspots.

Authors:  Isabella Eckerle; Benjamin Meyer
Journal:  Lancet       Date:  2020-07-06       Impact factor: 79.321

2.  Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets.

Authors:  Su-Jin Park; Kwang-Min Yu; Young-Il Kim; Se-Mi Kim; Eun-Ha Kim; Seong-Gyu Kim; Eun Ji Kim; Mark Anthony B Casel; Rare Rollon; Seung-Gyu Jang; Min-Hyeok Lee; Jae-Hyung Chang; Min-Suk Song; Hye Won Jeong; Younho Choi; Weiqiang Chen; Woo-Jin Shin; Jae U Jung; Young Ki Choi
Journal:  mBio       Date:  2020-05-22       Impact factor: 7.867

3.  Early diagnosis and rapid isolation: response to COVID-19 outbreak in Korea.

Authors:  K R Peck
Journal:  Clin Microbiol Infect       Date:  2020-04-25       Impact factor: 8.067

4.  Association between age and clinical characteristics and outcomes of COVID-19.

Authors:  Yang Liu; Bei Mao; Shuo Liang; Jia-Wei Yang; Hai-Wen Lu; Yan-Hua Chai; Lan Wang; Li Zhang; Qiu-Hong Li; Lan Zhao; Yan He; Xiao-Long Gu; Xiao-Bin Ji; Li Li; Zhi-Jun Jie; Qiang Li; Xiang-Yang Li; Hong-Zhou Lu; Wen-Hong Zhang; Yuan-Lin Song; Jie-Ming Qu; Jin-Fu Xu
Journal:  Eur Respir J       Date:  2020-05-27       Impact factor: 16.671

5.  Clinical Characteristics of Coronavirus Disease 2019 in China.

Authors:  Wei-Jie Guan; Zheng-Yi Ni; Yu Hu; Wen-Hua Liang; Chun-Quan Ou; Jian-Xing He; Lei Liu; Hong Shan; Chun-Liang Lei; David S C Hui; Bin Du; Lan-Juan Li; Guang Zeng; Kwok-Yung Yuen; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Ping-Yan Chen; Jie Xiang; Shi-Yue Li; Jin-Lin Wang; Zi-Jing Liang; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Nan-Shan Zhong
Journal:  N Engl J Med       Date:  2020-02-28       Impact factor: 91.245

6.  SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity.

Authors:  Benjamin Trinité; Ferran Tarrés-Freixas; Jordi Rodon; Edwards Pradenas; Víctor Urrea; Silvia Marfil; María Luisa Rodríguez de la Concepción; Carlos Ávila-Nieto; Carmen Aguilar-Gurrieri; Ana Barajas; Raquel Ortiz; Roger Paredes; Lourdes Mateu; Alfonso Valencia; Víctor Guallar; Lidia Ruiz; Eulàlia Grau; Marta Massanella; Jordi Puig; Anna Chamorro; Nuria Izquierdo-Useros; Joaquim Segalés; Bonaventura Clotet; Jorge Carrillo; Júlia Vergara-Alert; Julià Blanco
Journal:  Sci Rep       Date:  2021-01-28       Impact factor: 4.379

7.  Natural History of Asymptomatic SARS-CoV-2 Infection.

Authors:  Aki Sakurai; Toshiharu Sasaki; Shigeo Kato; Masamichi Hayashi; Sei-Ichiro Tsuzuki; Takuma Ishihara; Mitsunaga Iwata; Zenichi Morise; Yohei Doi
Journal:  N Engl J Med       Date:  2020-06-12       Impact factor: 91.245

8.  Early Epidemiological and Clinical Characteristics of 28 Cases of Coronavirus Disease in South Korea.

Authors: 
Journal:  Osong Public Health Res Perspect       Date:  2020-02

9.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.